ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab

Journal: Journal of Clinical Research and Ophthalmology (Vol.2, No. 2)

Publication Date:

Authors : ; ;

Page : 015-018

Keywords : ;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant.

Last modified: 2018-08-28 18:44:52